XML 36 R20.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Net Earnings (Loss) per Share
 6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Net Earnings (Loss) per Share Net Earnings (Loss) per Share
The basic weighted average shares and common stock equivalents for the three and six months ended June 30, 2024 and 2023, were computed using the treasury stock method.
The following table summarizes net earnings and net earnings per share attributable to FIS common stockholders for the three and six months ended June 30, 2024 and 2023 (in millions, except per share amounts):
 Three months ended June 30,Six months ended June 30,
 2024202320242023
Net earnings (loss) from continuing operations attributable to FIS common stockholders$242 $84 $259 $180 
Net earnings (loss) from discontinued operations attributable to FIS common stockholders1 (6,680)709 (6,636)
Net earnings (loss) attributable to FIS common stockholders$243 $(6,596)$968 $(6,456)
Weighted average shares outstanding-basic554 592 565 592 
Plus: Common stock equivalent shares3 — 2 — 
Weighted average shares outstanding-diluted557 592 567 592 
Net earnings (loss) per share-basic from continuing operations attributable to FIS common stockholders$0.44 $0.14 $0.46 $0.30 
Net earnings (loss) per share-basic from discontinued operations attributable to FIS common stockholders— (11.28)1.25 (11.21)
Net earnings (loss) per share-basic attributable to FIS common stockholders$0.44 $(11.14)$1.71 $(10.91)
Net earnings (loss) per share-diluted from continuing operations attributable to FIS common stockholders$0.43 $0.14 $0.46 $0.30 
Net earnings (loss) per share-diluted from discontinued operations attributable to FIS common stockholders— (11.28)1.25 (11.21)
Net earnings (loss) per share-diluted attributable to FIS common stockholders$0.44 $(11.14)$1.71 $(10.91)

The diluted net loss per share for the three and six months ended June 30, 2023, did not include the effect of common stock equivalent shares of 2 million and 1 million, respectively, because the effect would have been anti-dilutive. Options to purchase approximately 7 million and 9 million shares of our common stock during the three months, and 7 million and 9 million during the six months, ended June 30, 2024 and 2023, respectively, were not included in the computation of diluted earnings per share because they were anti-dilutive.

In January 2021, our Board of Directors approved a share repurchase program under which it authorized the Company to repurchase up to 100 million shares of our common stock. In August 2024, our Board of Directors approved a separate, incremental share repurchase program authorizing the repurchase of up to $3.0 billion in aggregate value of shares of our common stock. Repurchases under these programs will be made at management's discretion from time to time on the open market or in privately negotiated transactions and through Rule 10b5-1 plans. Neither of these repurchase programs has an expiration date, and either program may be suspended for periods, amended or discontinued at any time. Approximately 20 million shares remained available for repurchase under the January 2021 program as of June 30, 2024, and the Company will exhaust its authorization under this program prior to repurchasing shares under the new program.